Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA

Archives of Dermatological Research

Volumn 290, Issue 8, 1998, Pages 458-461

  Hofbauer, Günther F L ^a   Dummer, Reinhard ^a   Laine, Elisabeth ^a   Burg, Günter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

gp100; MAGE 3; Melan A MART 1; Melanoma; Melanoma associated antigens; MUC18; RT PCR ELISA; Tyrosinase

Indexed keywords

MELANOMA ANTIGEN; MESSENGER RNA;

ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MELANOMA; MELANOMA CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SERODIAGNOSIS;

ANTIGENS, CD; ANTIGENS, CD146; ANTIGENS, NEOPLASM; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMANS; MELANOMA; MEMBRANE GLYCOPROTEINS; MONOPHENOL MONOOXYGENASE; NEOPLASM PROTEINS; NEURAL CELL ADHESION MOLECULES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031688307     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004030050337     Document Type: Article

References (24)

1. Adema GJ, de Boer AJ, Vogel AM, Loenen WA, Figdor CG (1994) Molecular characterization of the melanocyte lineage-specific antigen gp100. J Biol Chem 269:20126-20133
2. Albino AP, Fountain JW (1993) Molecular genetics of human malignant melanoma. Cancer Treat Res 65:201-255
3. Altschul S, Gish W, Miller W, Myers E, Lipman D (1990) Basic local alignment search tool. J Mol Biol 215:403-410
4. Bakker AB, Schreurs MW, de Boer AJ, Kawakami Y, Rosenberg SA, Adema GJ, Figdor CG (1994) Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J Exp Med 179:1005-1009
5. Becker JC, Termeer C, Schmidt RE, Brocker EB (1993) Soluble intercellular adhesion molecule-1 inhibits MHC-restricted specific T cell/tumor interaction. J Immunol 151:7224-7232
6. Brasseur F, Rimoldi D, Lienard D, Lethe B, Carrel S, Arienti F, Suter L, Vanwijck R, Bourlond A, Humblet Y, Vacca A, Conese M, Lahaye T, Degiovanni G, Deremaecker R, Beauduin M, Sastre X, Salamon E, Dreno B, Jäger B, Knuth A, Chevreau C, Suciu S, Lachapelle J, Pouillart P, Parmiani G, Lejeune F, Cerottini J, Boon T, Marchand M (1995) Expression of MAGE genes in primary and metastatic cutaneous melanoma. Int J Cancer 63:375-380
7. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489-495
8. Chen YT, Stockert E, Tsang S, Coplan KA, Old LJ (1995) Immunophenotyping of melanomas for tyrosinase: implications for vaccine development. Proc Natl Acad Sci USA 92: 8125-8129
9. Dummer R, Heald PW, Nestle FO, Ludwig E, Laine E, Hemmi S, Burg G (1996) Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 88:1383-1389
10. Dummer R, Yue F-Y, Pavlovic J, Geertsen R, Doehring C, Moelling K, Burg G (1998) Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin-10. Br J Cancer 77: 1413-1419
11. Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethe B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921-930
12. Geertsen R, Hotbauer G, Yue F-Y, Burg G, Dummer R (1998) Selective loss of HLA class I A- and B- allospecificities occurs preferentially in melanoma metastases. J Invest Dermatol (in press)
13. Hofbauer GFL, Schaefer C, Noppen C, Böni R, Kamarashev J, Spagnioli G, Dummer R (1997) MAGE-3 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Am J Pathol 151:1549-1553
14. Hofbauer G, Kamarashev J, Geertsen R, Böni R, Dummer R (1998) Tyrosinase immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. J Cutan Pathol 25:204-209
15. Hofbauer GFL, Kamarashev J, Geertsen R, Böni R, Dummer R (1998) MelanA/MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution. Melanoma Res (in press)
16. Hofmann S, Remy W, Borelli S Jr, von Reis A, Weidinger S (1996) Nachweis von Tyrosinase-mRNA mittels Reverser Transkription/Polymerasekettenreaktion an Feinnadelpunktaten von Melanommetastasen. Hautarzt 47:197-199
17. Hoon DS, Wang Y, Dale PS, Conrad AJ, Schmid P, Garrison D, Kuo C, Foshag LJ, Nizze AJ, Morton DL (1995) Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 13:2109-2116
18. Johnson JP, Rothbacher U, Sers C (1993) The progression associated antigen MUC18: a unique member of the immunoglobulin supergene family. Melanoma Res 3:337-340
19. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA (1994) Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515-3519
20. Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA (1994) Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proc Natl Acad Sci USA 91:6458-6462
21. Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PF, Rivoltini L, Yannelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes. J Exp Med 180:347-352
22. Schadendorf D, Fichtner I, Makki A, Alijagic S, Kupper M, Mrowietz U, Henz BM (1996) Metastatic potential of human melanoma cells in nude mice - characterisation of phenotype, cytokine secretion and tumour-associated antigens. Br J Cancer 74:194-199
23. Shih IM, Elder DE, Hsu MY, Herlyn M (1994) Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol 145:837-845
24. Wagner SN, Wagner C, Schultewolter T, Goos M (1997) Analysis of Pme117/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. Cancer Immunol Immunother 44:239-247